Desjardins Global Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $1.85M | Buy |
3,922
+44
| +1% | +$20.7K | 0.2% | 123 |
|
|
2023
Q3 | $1.69M | Buy |
3,878
+355
| +10% | +$155K | 0.18% | 127 |
|
|
2023
Q2 | $1.57M | Buy |
3,523
+256
| +8% | +$114K | 0.18% | 134 |
|
|
2023
Q1 | $1.5M | Buy |
3,267
+924
| +39% | +$425K | 0.19% | 108 |
|
|
2022
Q4 | $1.2M | Sell |
2,343
-358
| -13% | -$184K | 0.19% | 116 |
|
|
2022
Q3 | $1.23M | Buy |
2,701
+20
| +0.7% | +$9.09K | 0.16% | 136 |
|
|
2022
Q2 | $1.29M | Buy |
2,681
+155
| +6% | +$74.8K | 0.17% | 133 |
|
|
2022
Q1 | $1.24M | Buy |
2,526
+62
| +3% | +$30.5K | 0.11% | 174 |
|
|
2021
Q4 | $1.14M | Buy |
+2,464
| New | +$1.14M | 0.1% | 187 |
|